Clinical trial
A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid…
NCT00329004 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00329004 |
|---|---|
| Title | A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors |
| Official title | A Phase I Dose Escalation Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer, Tumor |
| Intervention type | Drug |
| Interventions | BMS-690514 |
| Enrollment | 89 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | May 24, 2006 |
| Last update posted | Jan 25, 2011 |
| Countries | Canada, France, Spain, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: